Evidence map›Paper›PMID 21382398›Full record

ReviewPharmacology, biochemistry, and behavior2011

The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation.

Julie A Dumas, Paul A Newhouse

Abstract readReview
In one paragraph

Review in Pharmacology, biochemistry, and behavior, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 213 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study.Journal of cancer survivorship : research and practice · 2019
    Trial
  5. Trial
  6. Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Trial
  7. Trial
  8. Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Brain cholinergic terminal density utilizing [Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  17. Article
  18. Dopamine alters functional gradients in Parkinson's disease.Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Julie A DumasClinical Neuroscience Research Unit and Brain Imaging Program, Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT 05401, USA. Julie.Dumas@uvm.edu
Paul A Newhouse
University of Vermont · US

Funding

Estrogen Effects on Cholinergic Function in Older WomenR01AG021476 · NIA · VANDERBILT UNIVERSITY · PI NEWHOUSE, PAUL A. · 2003 to 2013
$4.2M
Hormone and Neurotransmitter Interactions in Cognitive AgingK01AG030380 · NIA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI DUMAS, JULIE A · 2008 to 2012
$650k
NIA NIH HHS K01 AG030380NIA NIH HHS R01 AG021476
6 · The paper itself

Abstract

It is now possible to reevaluate the cholinergic hypothesis of age-related cognitive dysfunction based on a synthesis of new evidence from cholinergic stimulation studies and cognitive models. We propose that a change of functional circuitry that can be observed through a combination of pharmacologic challenge and functional neuroimaging is associated with age-related changes in cholinergic system functioning. Psychopharmacological manipulations using cholinergic agonists and antagonists have been consistent in replicating patterns of aging seen in functional imaging studies. In addition, studies of anticholinesterase drugs in patients with Alzheimer's disease and mild cognitive impairment show support for the proposal that cholinergic compensation causes alterations in task-related brain activity. Thus, the cholinergic hypothesis of age-related cognitive dysfunction deserves further consideration as new methodologies for evaluating its validity are increasingly being used. Future directions for testing hypotheses generated from this model are presented.

Indexed as

AcetylcholineAgingAlzheimer DiseaseCognitionCognition DisordersHumansModels, NeurologicalModels, PsychologicalNootropic AgentsReceptors, CholinergicAcetylcholineNootropic AgentsReceptors, Cholinergic

Identifiers

PMID21382398
PMCPMC3114182
OpenAlexW2014349545

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.